The basal-like breast cancer subtype, which commonly lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is widely perceived as being synonymous with triple-negative breast cancer [9]. Here, ERBB2 is linked to breast carcinoma.